본문 바로가기
investors

[Media Releases] [Yakup News]LegoChem Biosciences, 'BioSpectrim Asia Emerging Company of the Year 2012 Award.'

2015.06.26

Title: Yakup News – LegoChem Biosciences, 'BioSpectrim Asia Emerging Company of the Year 2012 Award.'

Publication: Yakup News

Date: 19 March 2012


Summary

  • LegoChem Bioscience (CEO Yong Zu Kim) won “BioSpectrum Asia Emerging Company of the Year 2012 Award” in The Fourth Biospectrum Asia Pacific Award, sponsored by international bio magazine BioSpectrum Asia.

 

To view the full article (in Korean), click here 

 

 

About LegoChem Biosciences

 

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).